Royal Philips has received FDA 510(k) clearance for Elevate Plus, an AI-enabled ultrasound software platform built to streamline routine abdominal exams, the Amsterdam-based health technology company said this week. The clearance lands Philips inside the same June 2026 AI imaging window that also saw FDA decisions for AIRS Medical's SwiftMR upgrade and Subtle Medical's SubtleHD(CT), tracked in our SubtleHD(CT) coverage.
Auto Measure Abdomen At 93 Percent Accuracy
Elevate Plus's flagship feature, Auto Measure Abdomen, automates multiple measurements during abdominal ultrasound exams with a 93 percent accuracy rate against sonographer ground truth, Philips said. The platform integrates into existing Philips ultrasound systems and is positioned at the volume end of the imaging workflow, where sonographer time per scan is the binding constraint on throughput rather than image quality alone.
The AI Imaging Workflow Push
Philips's strategy with Elevate Plus is clear: deepen AI-driven automation inside the bedside ultrasound workflow rather than chase a new imaging modality. The same pattern has played out across other major imaging vendors and AI startups through the first half of 2026, including the Penumbra Thunderbolt clearance on the interventional side and Microbot Medical's Liberty endovascular robot on the procedural side. Vendors win by removing measurement steps and quantifying confidence, not by building a parallel scanner.
Why The 510(k) Cadence Matters
Elevate Plus joins a steady cadence of AI-enabled 510(k) clearances in Q2 2026, including SwiftMR's expanded clearance for deep-learning MRI reconstruction at AIRS Medical and SubtleHD(CT)'s low-contrast detection clearance at Subtle Medical. For Philips, the regulatory throughput is a hedge against rival platforms from GE HealthCare and Siemens Healthineers, which both have competing AI ultrasound tools in their own 510(k) pipelines. For health systems, the practical implication is that AI-assisted automation is moving from optional add-on to default expectation in routine exam workflows.
Field Deployment Timing
Philips did not disclose specific commercial launch volumes for Elevate Plus, but the company has historically shipped FDA-cleared ultrasound software updates to existing fleet customers within the same fiscal quarter as clearance under its enterprise services contracts. That cadence, if maintained, would put Elevate Plus into US imaging centers before year-end 2026, with Auto Measure Abdomen likely the first feature to see broad adoption given its measurable workflow-time savings.
Reporting based on coverage from Diagnostic Imaging and FDA 510(k) database filings.